Ranran Shi

机构：Shandong Provincial Hospital, Luohe Medical College, Shandong First Medical University · ORCID：0000-0002-8352-0452

发表论文 55 篇 · 总被引 759 次 · h-index 17

代表论文

• Retraction Note to: CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma (2017 · Molecular Neurobiology · 被引 20)
• New thymol and isothymol derivatives from Eupatorium fortunei and their cytotoxic effects (2020 · Bioorganic Chemistry · 被引 18)
• Dynamic Change of Thyroid Hormones With Postmenstrual Age in Very Preterm Infants Born With Gestational Age <32 Weeks: A Multicenter Prospective Cohort Study (2021 · Frontiers in Endocrinology · 被引 12)
• Dual targeting of TIGIT and PD-1 with a novel small molecule for cancer immunotherapy (2024 · Biochemical Pharmacology · 被引 11)
• Retraction Note to “SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma” (2017 · Molecular Neurobiology · 被引 7)
• Presence of serum autoantibodies to vacuolar H+‐ATPase in patients with renal tubular acidosis (2019 · International Journal of Rheumatic Diseases · 被引 6)